QualityStocksNewsBreaks – Endonovo Therapeutics Inc. (ENDV) Names Strategic Advisor to CEO
Commercial-stage developer of innovative medical devices Endonovo Therapeutics (OTCQB: ENDV) recently named Dr. William Li, CEO and co-founder of the Angiogenesis Foundation, as a strategic advisor to the CEO. An article discussing the company reads, “The role of Li would be to strategically explore growth opportunities within the Endonovo target markets, the company said in a press release (http://ibn.fm/mCqAT). . . . ‘Dr. Li is a globally recognized medical professional and a business visionary with a strong track record of success,’ Endonovo Therapeutics CEO Alan Collier said in a news release. Just like the Endonovo team, Li sees the long-term potential…